Form 4: LIXTE Director Guy Primus Acquires 25,000 Stock Options

LIXTE BIOTECHNOLOGY HOLDINGS, INC. Director Guy Warren Primus acquired 25,000 stock options with an exercise price of $4.05, vesting over time.

Summary

• Guy Warren Primus, a Director of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), acquired 25,000 stock options.
• The transaction date for the option grant was December 24, 2025.
• The exercise price for these stock options is $4.05 per share.
• The options have an expiration date of December 24, 2030.
• Fifty percent (50%) of the options vested and became exercisable on the grant date, December 24, 2025.
• The remaining fifty percent (50%) will vest in equal installments of twelve and one-half percent (12.5%) on March 31, 2026, and on the last day of each subsequent calendar quarter thereafter until fully vested.
• Vesting is subject to Guy Warren Primus's continuous service through each applicable vesting date.
• The options represent the right to buy 25,000 shares of Common Stock.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a director is generally viewed as a positive signal, indicating management's confidence in the company's future growth and stock performance, as the options' value is tied to an increase in share price.

Positives

• A director acquiring stock options can signal confidence in the company's future prospects and potential stock price appreciation.
• The vesting schedule aligns the director's long-term interests with those of shareholders.

Future Outlook

The vesting schedule for the stock options extends into future calendar quarters, indicating an expectation of continued service from the director and aligning his incentives with the company's long-term performance.

Industry Context

This Form 4 filing is a standard disclosure of an insider equity transaction, common across all industries for publicly traded companies. It reflects a component of executive or director compensation within the biotechnology sector.

Management Changes

Corporate Governance

Related Party Transactions

• The stock option grant to Guy Warren Primus, a Director, constitutes an insider transaction, which is a form of related party dealing in the context of executive compensation.

Stakeholder Impact

• Shareholders: May view the director's acquisition of options as a positive indicator of confidence in the company's future, potentially influencing market sentiment.
• Employees: The compensation structure for directors can set a precedent or reflect the broader compensation philosophy within the company.

Next Steps

• Continued vesting of the remaining 50% of the stock options in quarterly installments, subject to continuous service.

Key Dates

Keywords

LIXTE BIOTECHNOLOGY HOLDINGS, LIXT, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, Guy Primus